Re. Santing et al., ROLE OF HISTAMINE IN ALLERGEN-INDUCED ASTHMATIC REACTIONS, BRONCHIAL HYPERREACTIVITY AND INFLAMMATION IN UNRESTRAINED GUINEA-PIGS, European journal of pharmacology, 254(1-2), 1994, pp. 49-57
In a new model using conscious, unrestrained and ovalbumin-sensitized
guinea pigs, we investigated the effects of the selective histamine H,
receptor antagonist, mepyramine, on the development of allergen-induc
ed early and late asthmatic reactions, bronchial hyperreactivity and a
irway inflammation, having each animal as its own control. In guinea p
igs responding to a first allergen exposure with an early as well as a
late asthmatic reaction (82% of the animals) a second, identical, all
ergen provocation was performed, in the absence (control) or presence
of 1 mg/ml mepyramine aerosol, inhaled for 10 min, 1 h before provocat
ion. The mepyramine treatment significantly reduced both early and lat
e asthmatic reactions and prevented the development of bronchial hyper
reactivity to histamine and methacholine after both reactions. Examina
tion of the bronchoalveolar lavage fluid 24 h after the second allerge
n provocation revealed a general reduction of inflammatory cells after
mepyramine treatment. The results indicate that histamine, release du
ring the early asthmatic reaction, contributes to the development of t
he late asthmatic reaction as well as of early and late bronchial hype
rreactivity, possibly via an effect on airway inflammation.